3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Prostatic Neoplasms
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Congenital Abnormalities
1
Blast Crisis
1
Interventions
fludarabine phosphate
6
Whole-Body Irradiation
5
Melphalan
5
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Cyclophosphamide
3
thymoglobulin
2
Tacrolimus
2
Methotrexate
2
Cyclosporine
2
Busulfan
2
Antilymphocyte Serum
2
Alemtuzumab
2
merphos
1
fludarabine
1
Thiotepa
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Muromonab-CD3
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Cyclosporins
1
Basiliximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hemoglobinuria, Paroxysmal
×
treosulfan
×
Clear all
No trials found.